Hyodeoxycholic acid attenuates atherosclerosis by antagonizing FXR and modulating the PD-1/mTORC1 signaling axis.

First, our clinical cohort, while revealing an associative trend, was of moderate size and lacked stratification by disease severity or data on dietary and gut microbiota factors that influence BA metabolism.

also in 11 other papers